Informatie:
Fout:
ID
21630
Beschrijving
Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00308087
Link
https://clinicaltrials.gov/show/NCT00308087
Trefwoorden
Versies (1)
- 27-04-17 27-04-17 -
Geüploaded op
27 april 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Lymphoma, Follicular NCT00308087
Eligibility Lymphoma, Follicular NCT00308087
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma, Follicular NCT00308087
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Follicular Lymphoma Relapse
Item
relapsed follicular b-cell lymphoma
boolean
C0024301 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,2])
Therapeutic procedure Quantity Non-Hodgkin Lymphoma
Item
one or more previous therapies for non-hodgkin's
boolean
C0087111 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0024305 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0024305 (UMLS CUI [1,3])
Measurable Disease Quantity X-Ray Computed Tomography | Measurable Disease Quantity Magnetic Resonance Imaging
Item
at least one measurable tumor by ct scan or mri
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0024485 (UMLS CUI [2,3])
C1265611 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0024485 (UMLS CUI [2,3])
Inclusion criteria Additional
Item
additional criteria to be determined at screening visit
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])
Exclusion Criteria
Item
exclusion criteria (abbreviated list):
boolean
C0680251 (UMLS CUI [1])
rituximab refractory | rituximab | Relapse
Item
rituximab refractory (less than 6 months from last treatment with rituximab to relapse)
boolean
C0393022 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
C0393022 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C0205269 (UMLS CUI [1,2])
C0393022 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
cancer treatment
Item
currently receiving treatment for another cancer
boolean
C0920425 (UMLS CUI [1])
Communicable Disease Treated
Item
infection currently being treated
boolean
C0009450 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,2])
Hepatitis B
Item
active hepatitis b
boolean
C0019163 (UMLS CUI [1])
HIV Infection
Item
history of hiv infection
boolean
C0019693 (UMLS CUI [1])
Pregnancy
Item
pregnant
boolean
C0032961 (UMLS CUI [1])
Exclusion Criteria Additional
Item
additional criteria to be determined at screening visit
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])